Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Protocol for enhancing production of human PSC-derived cardiomyocytes and endothelial cells with placental growth factor.

STAR protocols·2026

Same author

Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.

Journal of medicinal chemistry·2026

Same author

Halogen-Controlled Aromatic Interactions Drive the Self-Assembly and Mechanics of Peptide Hydrogels.

ACS applied bio materials·2026

Same author

Towards mRNA therapeutics 2.0.

Nature reviews. Drug discovery·2026

Same author

PEG-lipid structure controls in vitro PEG shedding, surface remodeling, and timing of lipid nanoparticle-mediated silencing.

Journal of colloid and interface science·2026

Same author

Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.

Cancer communications (London, England)·2026

Same journal

Scalable phosphotyrosine enrichment with SH2 superbinder enables deep profiling of EGF responses.

The EMBO journal·2026

Same journal

Essential nucleus-apical pole linkage maintains division fidelity during Plasmodium progeny formation.

The EMBO journal·2026

Same journal

From cell atlases to mechanisms: bridging scRNA-seq discovery with in vivo genetics.

The EMBO journal·2026

Same journal

Mitochondrial calcium regulates lipid metabolism by modulating tethering of mitochondria to lipid droplets.

The EMBO journal·2026

Same journal

Chromosome condensation mechanically primes the nucleus for mitosis.

The EMBO journal·2026

Same journal

NDR kinase SAX-1 controls dendrite branch-specific elimination during neuronal remodeling in C. elegans.

The EMBO journal·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 17, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Programming and reprogramming a human heart cell.

Makoto Sahara¹, Federica Santoro², Kenneth R Chien¹

¹Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden Department of Medicine-Cardiology, Karolinska Institute, Stockholm, Sweden makoto.sahara@ki.se kenneth.chien@ki.se.

The EMBO Journal

|February 26, 2015

Summary

This summary is machine-generated.

Stem cell biology and developmental cardiology offer promise for cardiac regeneration. Deeper understanding of human heart cell programming and reprogramming is crucial for advancing cardiac regenerative therapeutics toward clinical practice.

Keywords:

cardiac progenitor cell cardiac regeneration cardiomyocyte proliferation embryonic heart field reprogramming

More Related Videos

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

Related Experiment Videos

Last Updated: Apr 17, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

Area of Science:

Stem cell biology
Developmental cardiology
Cardiac regenerative medicine

Background:

Recent advances in stem cell biology and developmental cardiology show promise for regenerating cardiac muscle in diseased hearts.
However, progress is limited by a lack of reproducible evidence, resulting in modest outcomes and hindering clinical translation.
A deeper understanding of human cardiogenesis and cardiac regeneration is essential to overcome current challenges.

Purpose of the Study:

To review fundamental principles of human heart cell programming and reprogramming.
To discuss updated therapeutic strategies for cardiac regeneration in damaged hearts.
To address controversies and advance cardiac regenerative therapeutics.

Main Methods:

Review of current literature on stem cell biology and developmental cardiology.
Analysis of cellular and molecular programs in human cardiogenesis and regeneration.
Discussion of established and emerging therapeutic strategies.

Main Results:

Stem cell discoveries provide potential tools for cardiac regeneration.
Understanding cellular programming and reprogramming is key to developing effective therapies.
Current strategies show modest outcomes, necessitating further research.

Conclusions:

Continued research into human heart cell programming is vital for advancing cardiac regenerative medicine.
Novel therapeutic strategies are emerging but require more robust evidence for clinical application.
Bridging the gap between basic science and clinical practice is essential for treating heart disease.